Alphabet’s life sciences offshoot Verily said Friday that it has raised $1 billion to fuel its next stage of development — one that will be steered by a new corporate leader as CEO Andy Conrad plans to shift to an advisory role.
In the News
Share
Alphabet spinout Verily raises $1 billion as it looks to harness health data
More News
UPMC is using AI model for breast cancer sentinel node biopsies
September 16, 2022
CVS Health to purchase Signify Health for $8B
September 14, 2022
